Paid Clinical Trials Cincinnati

Discover 1,125 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,125

FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Fate Therapeutics

Location:

Cincinnati OH, Columbus OH, Detroit MI, Nashville TNshow 10 more

Code:

NCT06241456

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

Observational StudySimplified Ultrasound Feedback for Speech Remediation

Recruiting

Sponsor:

University of Cincinnati

Location:

Cincinnati OH

Code:

NCT06366256

Conditions

Speech Sound Disorder

Eligibility Criteria

Sex: All

Age: 7 - 17

Healthy Volunteers: Not accepted

Interventions

Traditional ultrasound biofeedback

Simplified ultrasound biofeedback

MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD

Recruiting

PHASE3

Sponsor:

Ironshore Pharmaceuticals and Development, Inc

Location:

Cincinnati OH, Saint Charles MO, Decatur GA, Memphis TNshow 9 more

Code:

NCT06431256

Conditions

Attention Deficit Hyperactivity Disorder

Eligibility Criteria

Sex: All

Age: 4 - 5

Healthy Volunteers: Not accepted

Interventions

HLD200 methylphenidate hydrochloride capsules

Placebo HLD200 capsules

Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Recruiting

PHASE3

Sponsor:

Canadian Cancer Trials Group

Location:

Cincinnati OH, Franklin OH, Centerville OH, Dayton OHshow 52 more

Code:

NCT06205485

Conditions

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Leucovorin

Oxaliplatin

Fluoruracil

Capecitabine

Radiation

NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Recruiting

Sponsor:

Jaeb Center for Health Research

Location:

Cincinnati OH, Lexington KY, Cleveland OH, Chicago ILshow 13 more

Code:

NCT05639556

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMI and lean mass index from DXA

Anthropometric Measurements

Hand-grip strength

Six-minute walk Test

Sit-to-Stand Test

BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Recruiting

PHASE2

PHASE3

Sponsor:

Blueprint Medicines Corporation

Location:

Cincinnati OH, Ann Arbor MI, Buffalo NY, Birmingham ALshow 6 more

Code:

NCT04910685

Conditions

Indolent Systemic Mastocytosis

Monoclonal Mast Cell Activation Syndrome

Smoldering Systemic Mastocytosis

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Elenestinib

Placebo

Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry

Recruiting

Sponsor:

Parkinson's Foundation

Location:

Cincinnati OH, Lexington KY, Indianapolis IN, Columbus OHshow 42 more

Code:

NCT04994015

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lab Assay for seven genetic variants for Parkinson's Disease

Thrombectomy PlatformStrokeNet Thrombectomy Endovascular Platform

Recruiting

Sponsor:

Medical University of South Carolina

Location:

Cincinnati OH, Columbus OH, Pittsburgh PA, Saint Louis MOshow 26 more

Code:

NCT06289985

Conditions

Ischemic Stroke

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Endovascular thrombectomy with any FDA-approved category POL or NRY device

Medical Management

IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting

PHASE2

PHASE3

Sponsor:

IDEAYA Biosciences

Location:

Cincinnati OH, Cleveland OH, Nashville TN, Pittsburg PAshow 24 more

Code:

NCT05987332

Conditions

Metastatic Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Crizotinib

Pembrolizumab

Ipilimumab

Nivolumab

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE1

Sponsor:

TeneoOne Inc.

Location:

Cincinnati OH, Fort Wayne IN, Nashville TN, Hinsdale ILshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

Paid Clinical Trials Cincinnati

Filter results

FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors

Observational StudySimplified Ultrasound Feedback for Speech Remediation

MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD

Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Interested in new trials?

BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry

Thrombectomy PlatformStrokeNet Thrombectomy Endovascular Platform

IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma